Records containing: Locally Advanced Malignant Solid Neoplasm

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study results posted · 2026-10-02
Testing the Utility of a Novel Website to Help Cancer Patients Plan for Their Future - Phase 2
CLINICAL_TRIALS study record update · 2026-04-27
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
CLINICAL_TRIALS study record update · 2026-04-24
A Phase 2 Study of AZD1775 in SETD2-Deficient Advanced Solid Tumor Malignancies
CLINICAL_TRIALS study record update · 2026-04-24
Molecular Analysis for Combination Therapy Choice (ComboMATCH)
CLINICAL_TRIALS study record update · 2026-04-23
Phase II Trial of Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Selected Solid Tumor Malignancies
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2026-04-16
A Phase II Basket Study of the Oral TRK Inhibitor Larotrectinib (BAY2757556) in Subjects With NTRK Amplification Positive and Pan-TRK Positive Tumors
CLINICAL_TRIALS study record update · 2026-04-15
Can You Hear Me? Assessment of Verbal Comprehension and Cognitive Processes in Patients in the Last Days of Life
CLINICAL_TRIALS study record update · 2026-04-13
Phase 1 Study of Trastuzumab Deruxtecan (DS-8201a) in Combination With Azenosertib (ZN-c3) in HER2-Expressing/Amplified Gastric/Gastroesophageal Junction Cancer and Other Solid Tumors
CLINICAL_TRIALS study record update · 2026-04-13
A Phase I/II Study of M3814 and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
CLINICAL_TRIALS study record update · 2026-04-13
DURVA+ : Evaluation of the Safety and Pharmacodynamics of Anti-PD-L1 Antibody Durvalumab in Combination With Chemotherapy in Patients With Advanced Solid Tumors
CLINICAL_TRIALS study record update · 2026-04-13
Phase 2 Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants With PTEN/AKT-Altered Advanced Non-Breast Solid Tumors: A ComboMATCH Treatment Trial
CLINICAL_TRIALS study record update · 2026-04-13
A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response
CLINICAL_TRIALS study record update · 2026-03-12
A Phase I/II Study of Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab in Advanced Solid Tumors (PNeoVCA)
CLINICAL_TRIALS study record update · 2026-03-02
Phase 2 Study of Avapritinib in Patients With CKIT or PDGFRA Mutation-Positive Malignant Solid Tumors
CLINICAL_TRIALS study record update · 2026-02-27
Testing the Utility of a Novel Website to Help Cancer Patients Plan for Their Future - Phase 2
CLINICAL_TRIALS study record update · 2026-02-17
The Seena Magowitz Phase IB/II Trial of CMP-001 (a TLR9 Agonist) in Combination With INCAGN01949 (an Activating Anti-OX40 Antibody) for In Situ Intratumoral Injection for Patients With Stage IV Pancreatic and Other Cancers Except Melanoma
CLINICAL_TRIALS study record update · 2026-01-14
The Adoption of Audio Recording in the Outpatient Supportive Care Center
CLINICAL_TRIALS study record update · 2025-12-26
Maximizing Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer Types
CLINICAL_TRIALS study record update · 2025-12-26
A Combination Therapy for Cancer-Related Fatigue in Advanced Cancer Patients
CLINICAL_TRIALS study record update · 2025-12-24
A Phase 1 Safety and Efficacy Study of STIL101 for Injection in Locally Advanced, Unresectable, or Metastatic Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Renal Cell Carcinoma, Cervical Cancer, and Melanoma
CLINICAL_TRIALS study record update · 2025-11-10
A Phase I/Ib Dose Escalation and Biomarker Study of Ceritinib (LDK378) in Combination With Everolimus in Patients With Locally Advanced or Metastatic Solid Tumors With an Expansion in NSCLC Characterized by Abnormalities in Anaplastic Lymphoma Kinase (ALK) Expression
CLINICAL_TRIALS study record update · 2025-09-17
A Phase I Trial of the P97 Inhibitor CB-5339 in Patients With Advanced Solid Tumors and Lymphomas
CLINICAL_TRIALS study record update · 2025-08-14
Latinos' Beliefs and Communication About Advance Care Planning
CLINICAL_TRIALS study record update · 2025-05-13
Neoadjuvant Pembrolizumab for Patients With Mismatch Repair Deficient Locally Advanced Solid Cancers
CLINICAL_TRIALS study record update · 2024-09-19
Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced Cancer